List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
A ONE WEEK SUSTAINED RELEASE OF CLONAZEPAM
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
BIODEGRADABLE GUIDES FOR PERIPHERAL NERVE REGENERATION
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
IMMUNOTHERAPY OF ALZHEIMERS DISEASE
SBC: BOSTON BIOTECHNOLOGY CORPORATION Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
SAFE CAGING FOR TRAINING HUSBANDRY TASKS TO PRIMATES
SBC: BRITZ-HEIDBRINK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
Cell Lines with Receptors Important to Mental Health
SBC: Bunsen Rush Laboratories, Inc. Topic: N/AThe long-term objective of this project is to develop cell lines that stably express G-protein coupreceptors important to mental health. The specific aim of this application is to demonstrate the feaby developing a permanent cell line expressing the human D1 dopamine receptor (d1R). Cell lines whicreceptors will be useful in functional assays for finding new ligands (drugs) which will be highly ss ...
SBIR Phase I 1995 Department of Health and Human Services -
SYNTHESIS OF PERDEUTERATED BUFFERS AND DETERGENTS
SBC: Cambridge Isotope Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
CCD-BASED FLUORESCENCE POLARIZATION ASSAY PLATE READER
SBC: CAMBRIDGE RESEARCH AND INSTRUMENTATION Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
SOLUBLE CALCIUM ORGANIC SALTS IN RESORBABLE BONE CEMENT
SBC: CAMBRIDGE SCIENTIFIC, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
RESORBABLE STRUCTURES
SBC: CAMBRIDGE SCIENTIFIC, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
Long Pulse Laser Treatment of Psoriasis
SBC: CANDELA CORPORATION Topic: N/AThe investigators will study the efficacy of long pulsed laser treatment for psoriasis. Psoriasis iwhich is often chronic in nature. Current treatment modalities do not result in a cure of this chroninvestigators wish to develop a safe and efficacious dye laser for psoriasis. The laser radiation wiselective absorption by erythrocytes in the capillaries of the dermal papillae. Subsequent thermal nm ...
SBIR Phase I 1995 Department of Health and Human Services